Slang Worldwide is a Toronto-based company consolidating brands along the regulated supply chain in the global cannabis industry, building a world class portfolio of assets. The Company is focused on acquiring and developing market-proven regional brands, as well as creating new brands to meet the needs of cannabis consumers worldwide. PowerOne acted as co-agent in the company?s $16.7M financing in March 2018.
ChondroGene Limited is focussed on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel Principle(TM), to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews’ first product in development, ColonSentry(TM), is a blood-based test that can detect colon cancer and pre-cancerous polyps.
Diagnos is a leader in artificial intelligence and healthcare technical services including algorithm development, data analysis, and image processing ever since 2001. DIAGNOS Inc. of Canada provides software solutions. The Company develops and publishes a knowledge extraction platform that allows for the enhancement and intelligent analysis of digital retinal images. DIAGNOS serves healthcare industry worldwide.
Elite Imaging, Inc. provides medical imaging and radiology services. The Company offers magnetic resonance imaging (MRI), healthcare screening, breast implants, digital mammography, x-ray, nuclear medicine, and echocardiography services. Elite Imaging serves customers in the United States.
Lorus Therapeutics Inc. (TSX: LOR) (the “Company”), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer.
MediPharm Labs, a contract and development and manufacturing company, brings a pharmaceutical perspective to the cannabis industry; working to internationally recognized pharma-quality standards, our cannabis products that are PURE, TRUSTED and PRECISELY DOSABLE for patients and end consumers. MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates for derivative products in Canada and Australia. It also provides cannabis contract processing services to licensed producers and growers; and tolling services to licensed cultivators in Canada. In addition, the company supplies purified cannabis concentrate raw materials and product formulations for ready-to-sell advanced cannabis products. Further, it engages in the real estate business. The company was founded in 2015 and is headquartered in Barrie, Canada.